【正文】 1 / 98目 錄1. 治療腫瘤用冷熱刀技術(shù) .....................................................................................................................12. 全身熱療技術(shù) .....................................................................................................................................23. 核磁共振成像超導(dǎo)磁鐵（）研制 ..............................................................................................34. 蛋白質(zhì)芯片技術(shù)及生物醫(yī)學(xué)應(yīng)用 .....................................................................................................45. 特異性抗體層析純化制備工藝 .........................................................................................................56. 新型抗病毒藥物— 復(fù)合干擾素 .........................................................................................................77. PEG 修飾長效重組蛋白質(zhì)藥物技術(shù) ................................................................................................88. 自發(fā)熒光殼聚糖微球制備及作為示蹤劑的應(yīng)用 .............................................................................99. 尺寸均一可控的海洋多糖微球與微囊的制備技術(shù) .......................................................................1010. 新型藥用納米材料及其制備技術(shù) ...................................................................................................1111. 長效基因工程蛋白質(zhì)和多肽藥物制劑開發(fā) ...................................................................................1212. 光合細(xì)菌水產(chǎn)凈水劑和飼料添加劑成套生產(chǎn)技術(shù) .......................................................................1313. 血液蛋白質(zhì)提取技術(shù) .......................................................................................................................1414. 牛奶蛋白質(zhì)分離純化技術(shù) ...............................................................................................................1515. 海藻硫酸酯多糖提取分離集成化新技術(shù) .......................................................................................1616. 天然產(chǎn)物提純關(guān)鍵技術(shù)與成套設(shè)備 ...............................................................................................1717. 超聲強(qiáng)化多相傳遞過程技術(shù)及裝置 ...............................................................................................1818. 天然產(chǎn)物快速分析檢測和質(zhì)量控制技術(shù)平臺 ...............................................................................1919. 集成自動化固體發(fā)酵生產(chǎn)高效 BT 生物農(nóng)藥 ................................................................................2020. 新型動物保健藥品的產(chǎn)業(yè)化 ...........................................................................................................2121. 治療敗血癥及自身免疫性疾病的抗體藥物 ...................................................................................2222. 抗老年癡呆癥的復(fù)合制劑 ...............................................................................................................2323. 抗帕金森綜合癥的復(fù)合制劑 ...........................................................................................................2424. 新型抗體制備平臺技術(shù) ...................................................................................................................2525. 藥物納米輸送系統(tǒng) ...........................................................................................................................2626. 病原快速檢測裝置分子馬達(dá)微動力生物傳感器 ..........................................................................2727. 分子識別的高通量和定量檢測 .......................................................................................................2828. 生物型人工肝臟支持系統(tǒng) ...............................................................................................................2929. 苦參總黃酮及其鹽的制備 ...............................................................................................................3030. 超臨界萃取中草藥有效組份 ...........................................................................................................3131. 微膠囊栓塞介入治療 .......................................................................................................................3232. 微膠囊細(xì)胞移植治療神經(jīng)/內(nèi)分泌疾病 ..........................................................................................3333. 漂浮/生物粘附型微囊克拉霉素新制劑 ..........................................................................................3434. 具有降血壓功能的鹿血活性肽的制備 ...........................................................................................3535. 新型醫(yī)用鈦合金表面涂層的制備與性能 .......................................................................................3636. 緩釋藥物冠動脈植入支架的研制 ...................................................................................................3737. 抗腫瘤海洋生物新藥 .......................................................................................................................3838. 化妝品殼聚糖添加劑的研制 ...........................................................................................................3939. 海藻碘晶技術(shù)開發(fā)項(xiàng)目 ...................................................................................................................4040. 海藻多糖膠囊研制 ...........................................................................................................................4141. 螺旋藻碘鹽 .......................................................................................................................................4242. 甲殼胺低聚糖中試合作研究 ...........................................................................................................4343. 中藥新藥“甘參膠囊”的臨床研究 ...................................................................................................4444. 現(xiàn)代中藥新藥的研究開發(fā) ...............................................................................................................4545. 環(huán)境可降解改性聚乳酸材料在醫(yī)療用品中的應(yīng)用 .......................................................................4646. 生物降解膽總管支架 .......................................................................................................................4747. 基于 MEMS 工藝的小型自動生化分析儀 .....................................................................................4848. 可控圖案化電紡絲纖維支架材料 ...................................................................................................4949. 靈芝孢子粉多糖項(xiàng)目 ...........................................................